Application of Platelet-Rich Plasma as a Stem Cell Treatment - an Attempt to Clarify a Common Public Misconception
In recent years, there has been a significant increase in the practice of regenerative medicine by health practitioners and direct-to-consumer businesses globally. Among different tools of regenerative medicine, platelet-rich plasma (PRP) and stem cell-based therapies have received considerable atte...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Published: |
Bentham Science Publishers
2024
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/47081/ https://doi.org/10.2174/1566524023666230511152646 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
my.um.eprints.47081 |
---|---|
record_format |
eprints |
spelling |
my.um.eprints.470812024-11-22T04:01:01Z http://eprints.um.edu.my/47081/ Application of Platelet-Rich Plasma as a Stem Cell Treatment - an Attempt to Clarify a Common Public Misconception Fareez, Ismail M. Liew, Fong Fong Widera, Darius Mayeen, Naiyareen Fareeza Mawya, Jannatul Abu Kasim, Noor Hayaty Haque, Nazmul QH Natural history R Medicine (General) In recent years, there has been a significant increase in the practice of regenerative medicine by health practitioners and direct-to-consumer businesses globally. Among different tools of regenerative medicine, platelet-rich plasma (PRP) and stem cell-based therapies have received considerable attention. The use of PRP, in particular, has gained popularity due to its easy access, simple processing techniques, and regenerative potential. However, it is important to address a common misconception amongst the general public equating to PRP and stem cells due to the demonstrated efficacy of PRP in treating musculoskeletal and dermatological disorders. Notably, PRP promotes regeneration by providing growth factors or other paracrine factors only. Therefore, it cannot replenish or replace the lost cells in conditions where a large number of cells are required to regenerate tissues and/or organs. In such cases, cell-based therapies are the preferred option. Additionally, other tools of regenerative medicine, such as bioprinting, organoids, and mechanobiology also rely on stem cells for their success. Hence, healthcare and commercial entities offering direct-to-customer regenerative therapies should not mislead the public by claiming that the application of PRP is a stem cell-based therapy. Furthermore, it is important for regulatory bodies to strictly monitor these profit-driven entities to prevent them from providing unregulated regenerative treatments and services that claim a broad variety of benefits with little proof of efficacy, safety concerns, and obscure scientific justification. Bentham Science Publishers 2024 Article PeerReviewed Fareez, Ismail M. and Liew, Fong Fong and Widera, Darius and Mayeen, Naiyareen Fareeza and Mawya, Jannatul and Abu Kasim, Noor Hayaty and Haque, Nazmul (2024) Application of Platelet-Rich Plasma as a Stem Cell Treatment - an Attempt to Clarify a Common Public Misconception. Current Molecular Medicine, 24 (6). pp. 689-701. ISSN 1566-5240, DOI https://doi.org/10.2174/1566524023666230511152646 <https://doi.org/10.2174/1566524023666230511152646>. https://doi.org/10.2174/1566524023666230511152646 10.2174/1566524023666230511152646 |
institution |
Universiti Malaya |
building |
UM Library |
collection |
Institutional Repository |
continent |
Asia |
country |
Malaysia |
content_provider |
Universiti Malaya |
content_source |
UM Research Repository |
url_provider |
http://eprints.um.edu.my/ |
topic |
QH Natural history R Medicine (General) |
spellingShingle |
QH Natural history R Medicine (General) Fareez, Ismail M. Liew, Fong Fong Widera, Darius Mayeen, Naiyareen Fareeza Mawya, Jannatul Abu Kasim, Noor Hayaty Haque, Nazmul Application of Platelet-Rich Plasma as a Stem Cell Treatment - an Attempt to Clarify a Common Public Misconception |
description |
In recent years, there has been a significant increase in the practice of regenerative medicine by health practitioners and direct-to-consumer businesses globally. Among different tools of regenerative medicine, platelet-rich plasma (PRP) and stem cell-based therapies have received considerable attention. The use of PRP, in particular, has gained popularity due to its easy access, simple processing techniques, and regenerative potential. However, it is important to address a common misconception amongst the general public equating to PRP and stem cells due to the demonstrated efficacy of PRP in treating musculoskeletal and dermatological disorders. Notably, PRP promotes regeneration by providing growth factors or other paracrine factors only. Therefore, it cannot replenish or replace the lost cells in conditions where a large number of cells are required to regenerate tissues and/or organs. In such cases, cell-based therapies are the preferred option. Additionally, other tools of regenerative medicine, such as bioprinting, organoids, and mechanobiology also rely on stem cells for their success. Hence, healthcare and commercial entities offering direct-to-customer regenerative therapies should not mislead the public by claiming that the application of PRP is a stem cell-based therapy. Furthermore, it is important for regulatory bodies to strictly monitor these profit-driven entities to prevent them from providing unregulated regenerative treatments and services that claim a broad variety of benefits with little proof of efficacy, safety concerns, and obscure scientific justification. |
format |
Article |
author |
Fareez, Ismail M. Liew, Fong Fong Widera, Darius Mayeen, Naiyareen Fareeza Mawya, Jannatul Abu Kasim, Noor Hayaty Haque, Nazmul |
author_facet |
Fareez, Ismail M. Liew, Fong Fong Widera, Darius Mayeen, Naiyareen Fareeza Mawya, Jannatul Abu Kasim, Noor Hayaty Haque, Nazmul |
author_sort |
Fareez, Ismail M. |
title |
Application of Platelet-Rich Plasma as a Stem Cell Treatment - an Attempt to Clarify a Common Public Misconception |
title_short |
Application of Platelet-Rich Plasma as a Stem Cell Treatment - an Attempt to Clarify a Common Public Misconception |
title_full |
Application of Platelet-Rich Plasma as a Stem Cell Treatment - an Attempt to Clarify a Common Public Misconception |
title_fullStr |
Application of Platelet-Rich Plasma as a Stem Cell Treatment - an Attempt to Clarify a Common Public Misconception |
title_full_unstemmed |
Application of Platelet-Rich Plasma as a Stem Cell Treatment - an Attempt to Clarify a Common Public Misconception |
title_sort |
application of platelet-rich plasma as a stem cell treatment - an attempt to clarify a common public misconception |
publisher |
Bentham Science Publishers |
publishDate |
2024 |
url |
http://eprints.um.edu.my/47081/ https://doi.org/10.2174/1566524023666230511152646 |
_version_ |
1817841972608499712 |
score |
13.223943 |